Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)
Symptoms, Doctors, Treatments, Advances & More

Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A) Overview

Save information for later
Sign Up

Learn About Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)

View Main Condition: Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)

What is the definition of Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)?
Mucopolysaccharidosis type IVA (MPS IVA, also called Morquio syndrome, type A) is a metabolic condition that primarily affects the skeleton. The severity, age of onset, and associated symptoms vary significantly from person to person and range from a severe and rapidly progressive, early-onset form to a slowly progressive, later-onset form. The more severe form is usually diagnosed between ages 1 and 3, while the milder form may not become evident until late childhood or adolescence. Symptoms include various skeletal abnormalities such as short stature, knock knees, pectus carinatum, and malformations of the spine, hips and wrists. There may be involvement of other organ systems such as respiratory problems, valvular heart disease, hearing impairment, corneal clouding, dental abnormalities, hepatomegaly, and spinal cord compression. MPS IVA is caused by changes in the GALNS gene and is inherited in an autosomal recessive manner.
What are the alternative names for Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)?
  • Mucopolysaccharidosis type IVA
  • GALNS deficiency
  • Galactosamine-6-sulfatase deficiency
  • MPS 4A
  • MPS IVA
  • MPS4A
  • MPSIVA
  • Morquio A disease
  • Morquio disease type A
  • Morquio syndrome A
  • Mucopolysaccharidosis type 4A
  • N-acetylgalactosamine-6-sulfate sulfatase deficiency
Who are the top Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A) Local Doctors?
Elite in Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)
Roberto Giugliani
Elite in Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)
Roberto Giugliani
Porto Alegre, RS, BR 

Roberto Giugliani practices in Porto Alegre, Brazil. Mr. Giugliani is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A). His top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Acid Sphingomyelinase Deficiency (ASMD), Mucopolysaccharidosis Type 7 (MPS VII, Sly Syndrome), and Bone Marrow Transplant.

Elite in Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)
Andres F. Leal
Elite in Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)
Andres F. Leal
Bogota, DC, CO 

Andres Leal practices in Bogota, Colombia. Mr. Leal is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A). His top areas of expertise are Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A), Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome), Brachydactyly Mononen Type, and Mucopolysaccharidoses (MPS).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)
Dr. William Mackenzie
Orthopedics
Elite in Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)
Dr. William Mackenzie
Orthopedics

Nemours Children's Hospital Delaware

1600 Rockland Rd, 
Wilmington, DE 
302-651-4000
Languages Spoken:
English
See accepted insurances

William Mackenzie is an Orthopedics provider in Wilmington, Delaware. Dr. Mackenzie is rated as an Elite provider by MediFind in the treatment of Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A). His top areas of expertise are Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome), Brachydactyly Mononen Type, Achondroplasia, Osteotomy, and Spinal Fusion.

View All Doctors
What are the latest Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A) Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center